← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 24, 2017Last known activity
Sep 30, 2024
Timeline
2010s
- Jun 1, 2011
ChemomAb Ltd.— Founded
2020s
- Mar 16, 2021
Anchiano Therapeutics— Acquired
Drugs by trial phase (4 distinct, 13 trials)
Phase 2 (1 own, 2 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (10)
- NCT06210945Lead sponsorPhase 2Sep 30, 2024
- NCT06210945OfficialPhase 2Sep 30, 2024
- NCT05824156Study directorPhase 2Feb 24, 2021
- NCT05824156Lead sponsorPhase 2Feb 24, 2021
- NCT04595825Lead sponsorPhase 2Oct 1, 2020
- NCT06037577Study directorPhase 1Mar 5, 2019
- NCT06037577Lead sponsorPhase 1Mar 5, 2019
- NCT06044467Lead sponsorPhase 1Dec 11, 2018
- NCT06044467Study chairPhase 1Dec 11, 2018
- NCT06025851Lead sponsorPhase 1Jul 24, 2017
Details
- Founded
- Tel Aviv, IL Jun 1, 2011
- Last known activity
- Sep 30, 2024